当前位置： SCI文献检索 > 期刊下所有文献 > Repurposing the inhibitors of COVID-19 key proteins through molecular docking approach.

Repurposing the inhibitors of COVID-19 key proteins through molecular docking approach.

Abstract：

:The severe acute respiratory syndrome coronavirus 2, famous as COVID-19, has recently emerged as a novel virus and imposed an unrecoverable loss to global health and the economy. At present, no effective drug against COVID-19 is available and currently available viral drugs targeting the viral key proteins of related RNA viruses have been found ineffective against COVID-19. This study evaluated the inhibitors of the viral proteases and other structural proteins, including Mpro (Main protease), RdRp (RNA-dependent RNA polymerase), and spike glycoprotein from synthetic and herbal sources. The molecular docking-based approach was used to identify and evaluate the putative inhibitors of key proteins involved in viral replication and survival. Furthermore, the pharmaceutical properties of these inhibitors were explored to predict the drug suitability as a therapeutic agent against COVID-19 by considering adsorption, distribution, metabolism, and excretion (ADME) using Lipinski's rule or SwissADME. Trandolapril, Benazepril, and Moexipril were evaluated as the best non-carcinogenic and non-toxic potential inhibitors of spike glycoprotein, Mpro, and RdRp, respectively. The drugs showed significant binding affinities against the active sites of respective SARS_CoV-2 target proteins; hence, they can be used as potential therapeutic agents for the treatment of COVID-19.

journal_name

Process Biochem

journal_title

Process biochemistry (Barking, London, England)

authors

Alghamdi HA,Attique SA,Yan W,Arooj A,Albulym O,Zhu D,Bilal M,Nawaz MZ

doi

10.1016/j.procbio.2021.08.015

keywords:

["COVID-19","Docking","Drug suitability","Drug targets","Therapeutic targets"]

subject

Has Abstract

pub_date

2021-11-01 00:00:00

pages

216-222

eissn

1359-5113

issn

1873-3298

pii

S1359-5113(21)00256-7

journal_volume

110

pub_type

杂志文章

相关文献

文献大全
  • Optimization of the Production of the Lantibiotic Mutacin 1140 in Minimal Media.

    abstract：:Mutacin 1140 is produced by Streptococcus mutans and belongs to the type A lantibiotic family. Experiments were done to optimize production of mutacin 1140 in minimal media enabling a more cost efficient downstream purification method. The development of a small volume fermentation method enabled a rapid screen of sev...

    journal_title：Process biochemistry (Barking, London, England)

    pub_type： 杂志文章

    doi：10.1016/j.procbio.2010.03.031

    authors： Neeti D,Noel C,Dayna E,Shi-En L,Leif S

    更新日期：2010-07-01 00:00:00

  • Kinetic model for adherent Vero cell growth and poliovirus production in batch bioreactors.

    abstract：:The production of poliovirus vaccines in adherent Vero cells in batch bioreactors usually consists of a two-step upstream process: (1) Vero cell cultivation on microcarriers and (2) poliovirus proliferation. In this study we developed a mathematical model to describe this two-step process. We introduced the calculatio...

    journal_title：Process biochemistry (Barking, London, England)

    pub_type： 杂志文章

    doi：10.1016/j.procbio.2019.03.010

    authors： Jiang Y,van der Welle JE,Rubingh O,van Eikenhorst G,Bakker WAM,Thomassen YE

    更新日期：2019-06-01 00:00:00

  • A new chitin-binding lectin from rhizome of Setcreasea purpurea with antifungal, antiviral and apoptosis-inducing activities.

    abstract：:A 48 kDa, chitin-binding lectin with antifungal, antiviral and apoptosis-inducing activities was isolated from the rhizomes of Setcreasea purpurea Boom, a member of family Commelinaceae. Setcreasea purpurea lectin (designated as SPL) is a homotetrameric protein consisting of 12031.9 Da subunits linked by non-covalent ...

    journal_title：Process biochemistry (Barking, London, England)

    pub_type： 杂志文章

    doi：10.1016/j.procbio.2010.05.026

    authors： Yao Q,Wu CF,Luo P,Xiang XC,Liu JJ,Mou L,Bao JK

    更新日期：2010-09-01 00:00:00